期刊文献+

胆囊结石影响胆囊癌患者恶性贫血的发生 被引量:1

Effect of gallbladder stones on the pernicious anemia associated with gallbladder carcinoma
下载PDF
导出
摘要 目的探讨影响胆囊癌患者出现恶性贫血与胆囊结石的关系,为有效预防和控制胆囊癌相关的恶性贫血的发生提供参考.方法:回顾性分析195例胆囊癌患者资料,以是否合并胆囊结石进行分组,采用病例对照研究方法,分析胆囊结石与胆囊癌患者发生恶性贫血的关系.结果:根据胆囊癌患者是否合并癌性贫血进行分组,发现ALP、GGT、年龄、分化程度、是否伴有高血压、是否行胆囊切除术在胆囊癌患者贫血和无贫血组之间的差异有统计学意义.进一步分析胆囊癌患者合并胆囊结石对癌性贫血的影响,发现胆囊结石与癌性贫血的发生之间存在一定的联系(P〈0.001).对上述指标行Logistic 多因素分析,结果显示胆囊结石是胆囊癌患者发生恶性贫血的独立危险因素(P=0.01).结论:胆囊癌患者合并胆囊结石发生恶性贫血的风险高.临床上可以根据对胆囊结石的判断预防癌性贫血的发生. Objective To investigate the relation between pernicious anemia and history of cholecystolithiasis in gallbladder cancer and provide evidence to prevent and control pernicious anemia.Methods: The clinical records of 195 patients with gallbladder cancer admitted to the Department of hepatobiliary surgery, the First Affiliated Hospital of Medical College of Xian Jiaotong University from June 2006 to June 2015 were reviewed, and divide into two group according weather having cholecystolithiasis or not. Using a case-control design, the cholecystolithiasis relevant risk of appearing pernicious anemia was analyzed. Result: After independent variable assessment by univariate analysis, multivariate Logistic regression was conducted and the results demonstrated that cholecystolithiasis was the independent risk factors for the occurrence of pernicious anemia in gallbladder cancer (P=0.01).Conclusion: Cholecystolithiasis was the independent risk factors for the occurrence of pernicious anemia in gallbladder cancer. We can prevent anemia from gallbladder cancer by judging weather occur to gallstone.
出处 《世界中医药》 CAS 2015年第A02期1482-1483,共2页 World Chinese Medicine
关键词 胆囊癌 胆囊结石 恶性贫血 病例对照研究 Pernicious Anemia Cholecystolithiasis Gallbladder Cancer Diagnosis
  • 相关文献

参考文献16

  • 1Stinton LM, Shaffer EA. Epidemiology of gallbladder disease:cholelithiasis and cancer[J].Gut Liver,2012,6(2):172-187.
  • 2Grundmann RT1, Meyer F2. Gender-specific influencing factors onincidence, risk factors and outcome of carcinoma of the liver, gallbladder,extrahepatic bile duct and pancreas[J].Zentralbl Chir,2014,139(2):184-92.
  • 3Genc V, Onur Kirimker E, Akyol C,et al. Incidental gallbladdercancer diagnosed during or after laparoscopic cholecystectomy in members ofthe Turkish population with gallstone disease[J]. Turk J Gastroenterol,2011,22:513-516.
  • 4Heemskerk J, Nienhuijs SW. Gallstone ileus as first presentation of agallbladder carcinoma[J].J Gastrointestin Liver Dis,2009,18:253-254.
  • 5Mackinlay AG, Kaiser AD. DNA replication in head mutants ofbacteriophage lambda[J].J Mol Biol 1969;39:679-683.
  • 6Groopm an JE,ItriLM. Chemotherapy induced anemia inadults:incidence and treatment[J].J Nat lC ancer Inst,1999,91(19):1616.
  • 7Ludwig H, Van Belle S, Barrett-Lee P, Birgegard G, Bokemeyer C,Gascon P, Kosmidis P, et al. The European Cancer Anaemia Survey (ECAS):a large, multinational, prospective survey defining the prevalence, incidence,and treatment of anaemia in cancer patients[J].Eur J Cancer,2004,40:2293-2306.
  • 8Caro JJ, Salas M, Ward A, Goss G. Anemia as an independentprognostic factor for survival in patients with cancer: a systemic, quantitativereview[J].Cancer 2001;91:2214-2221.
  • 9Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of themaster iron regulator[J].Biosci Rep,2015;35.
  • 10Genc V, Onur Kirimker E, Akyol C,et al. Incidental gallbladdercancer diagnosed during or after laparoscopic cholecystectomy in members ofthe Turkish population with gallstone disease[J].Turk J Gastroenterol2011;22:513-516.

二级参考文献16

  • 1潘湘涛.癌性贫血的研究进展[J].临床荟萃,2006,21(21):1588-1589. 被引量:5
  • 2Weiss G, Goodnough LT. Anemia of chronic disease. New Engl J Med, 2005, 352 (10) : 1011-1023.
  • 3Glaspy J, Degos L, Dieato M, et al. Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum and nonplatinumbased chemotherapy:a retrospective subanalysis of two large, com- munity-based trials. The Oncologist, 2002, 7 (2) :126-135.
  • 4Grotto HZ. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Medoncol, 2008, 25 ( 1 ) : 12-21.
  • 5Varolotto J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oncol Biol Phys, 2005,63 (1) :25-36.
  • 6Raddino R, qobba D, Cartta G, et al. Erythropoietin:a new perspective in cardiovascular therapy. Monaldi Arch chest Dis, 2008, 70(4) :206-213.
  • 7Ferrario E, Ferrari L, Bidoli P, et al. Treatment of cancer-related anemia with epoetin alfa: a review. Cancer Treat Rev, 2004, 30 (6) :563-75.
  • 8Wilson J, Yao GL, Raftery J, et al. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepeetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess, 2007, 11 ( 13 ) : 201-202.
  • 9Mereadante S, Gebbia V, Marrazzo A, et al. Anaemia in cancer pathophysiology and treatment [ J ]. Cancer treat Rev,2000, 26(4) :303.
  • 10Bohlius J, Wilson J, Seidenfeld J, et al. Recombinant human erythropoietins and cancer patients updated meta analysis of 57 studies including 9353 patients [ J ]. J Natl Cancer Inst, 2006,98 (10) :708.

共引文献13

同被引文献24

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部